NCT04075890

Brief Summary

People utilize two behavioral strategies, goal-directed and habitual, when engaging in value-based decision-making that involves rewarding or punishing outcomes. Accumulating evidence suggests an imbalance between habitual and goal-directed behavior in favor of habitual control in parallel with exaggerated tendency toward compulsive/harm avoidance behavior in OCD. In healthy subjects, an arbitration mechanism has been proposed recently that controls the balance between those two strategies of action selection. Arbitration regions regulate the goal-directed/habitual decision-making balance by selectively downregulating the activity of the habitual regions. This project aims to explore the neurobehavioral characteristics of arbitration mechanism and its relationship with behaviors and clinical phenotypes in OCD by applying computational cognitive neuroscience, clinical task-based functional magnetic resonance imaging (fMRI) and transcranial direct current stimulation (tDCS) method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

December 12, 2025

Completed
Last Updated

December 12, 2025

Status Verified

November 1, 2025

Enrollment Period

4.6 years

First QC Date

August 29, 2019

Results QC Date

July 5, 2025

Last Update Submit

November 26, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Strength of Behaving Model-based (Goal-directed)

    Strength of behaving model-based (goal-directed) is measured and quantifiedas a continuous real number between 0 and 1. Here, having a strength's valueof 1 of behaving model-based means that subject in her/his decision-making,exclusively and always utilizes a model-based (goal-directed) strategy fordecision making and having a value of Zero means not utilizing model-based(goal-directed) strategy at all when decising.

    On the second or third session when subjects performed the task in the MRI scanner.

  • Reaction Time in Response to Stimuli With OCD Themes

    This is a time interval (in seconds) between the start of presentation of visual stimuli with OCD themes and when subjects pushed a bottom to stop the presentation when they could not tolerate those more during symptom provocation and avoidance task.

    On the second or third session when subjects performed the task in the MRI scanner.

  • Strength of Frontal Arbitration Modulation of Basal Ganglia Habit Region.

    Here, by applying Dynamic Causal Modeling (DCM) method, we measured thestrength of frontal arbitration (the interior frontal gyrus (IFG)) modulation ofbasal ganglia habit region (the posterolateral putamen) in terms of the effective(directed) connectivity between the interior frontal gyrus (IFG) andposterolateral putamen. This DCM-based effective connectivity can have avalue between -1 and +1. A value of -1 means a maximum effective connectivitybetween the interior frontal gyrus (IFG) and posterolateral putamen. A value of+1 means maximum excitatory effective connectivity between the interior frontalgyrus (IFG) and posterolateral putamen. And a value of 0 means no effectiveconnectivity between the interior frontal gyrus (IFG) and posterolateralputamen.

    On the second or third session when subjects performed the task in the MRI scanner

Study Arms (2)

Healthy subjects

ACTIVE COMPARATOR
Device: transcranial Direct Current Stimulation (tDCS)

OCD subjects

ACTIVE COMPARATOR
Device: transcranial Direct Current Stimulation (tDCS)

Interventions

tDCS is a non-invasive brain stimulation method by which constant low direct current can be delivered to the sculpt for changing the excitability of neuronal structure adjunct to the stimulating electrode.

Healthy subjectsOCD subjects

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-5 diagnostic criteria for OCD as primary (most severe) diagnosis (based on the Mini International Neuropsychiatric Interview).
  • Yale-Brown Obsessive-Compulsive Scale (YBOCS) total score is equal or greater than 16.
  • unmediated or being on a stable dose of medication (only SSRIs and clomipramine) for at least 12 weeks prior to the study.
  • fluent English speaker.
  • signed informed consent.

You may not qualify if:

  • IQ greater than 80 on the Wechsler Abbreviated Scales of Intelligence.
  • lifetime DSM-5 diagnosis of mania, psychotic disorder, or substance dependence (per MINI).
  • current DSM-5 diagnosis of MDD if Montgomery-Asberg Depression Scale (MADRS) scores are equal or greater than 35 (severe), or ADHD.
  • taking any psychotropic medication other than SSRIs or clomipramine.
  • severe psychiatric symptom that requires immediate inpatient psychiatric intervention such as suicidality.
  • presence of any serious psychiatric, psychosocial, or neurological condition requiring immediate treatment.
  • males and females age 18-65 years with signed informed consent and IQ greater than 80 on WASI.
  • presence of any MR scan contraindications particularly body metal or positive pregnancy test.
  • medical conditions in which cerebral metabolism might be compromised such as thyroid disorders, diabetes or current tobacco smoking (potential effect on imaging endpoints).
  • any history of seizure disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA

Los Angeles, California, 90095, United States

Location

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Results Point of Contact

Title
Reza Tadayon Nejad
Organization
UCLA

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor of Psychiatry

Study Record Dates

First Submitted

August 29, 2019

First Posted

September 3, 2019

Study Start

July 15, 2019

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

December 12, 2025

Results First Posted

December 12, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations